Nong Wenqian, Zhao Anran, Wei Jinrui, Lin Xiao, Wang Lisheng, Lin Cuiwu
Guangxi Colleges and Universities Key Laboratory of Applied Chemistry Technology and Resource Development, School of Chemistry & Chemical Engineer in Guangxi University, Nanning 530004, China.
Department of Chemistry, Cleveland State University, 2121 Euclid Avenue, Cleveland, OH 44115, United States.
Bioorg Med Chem Lett. 2017 Sep 15;27(18):4506-4511. doi: 10.1016/j.bmcl.2017.07.058. Epub 2017 Jul 22.
Ten new cinnamic acid derivatives containing a 2-aminothiazole substructure were designed and synthesized. This series of compounds exhibited good thermostabilities as demonstrated by thermogravimetric analysis. In coagulation assays (prothrombin time, activated partial thromboplastin time and thrombin time) in vitro, most compounds demonstrated excellent activities to promote blood coagulation. Among the studied series, compounds N1, N4, N5 and W5 exhibited a significant coagulation activity. Further studies indicated that compound N5 (IC=1.87μmol/L) displayed the most suitable efficacy of promoting platelet aggregation than the clinically used haemostatic drug etamsylate (IC=46.22μmol/L). Furthermore, the relationship between the functional groups of the compounds and the corresponding blood coagulant activity was explored in this study.
设计并合成了十种含有2-氨基噻唑亚结构的新型肉桂酸衍生物。热重分析表明,该系列化合物具有良好的热稳定性。在体外凝血试验(凝血酶原时间、活化部分凝血活酶时间和凝血酶时间)中,大多数化合物表现出优异的促凝血活性。在所研究的系列中,化合物N1、N4、N5和W5表现出显著的凝血活性。进一步研究表明,化合物N5(IC = 1.87μmol/L)比临床使用的止血药物酚磺乙胺(IC = 46.22μmol/L)表现出更合适的促进血小板聚集的功效。此外,本研究还探讨了化合物官能团与相应凝血活性之间的关系。